Egetis Therapeutics

Major Shareholding Notification • Nov 3, 2020

Issuer Egetis Therapeutics AB (publ)

Holder

Nortal Investments AB

Instrument

Instrument	AK SE0003815604
Before the transaction
Shares	6,592,034
Voting rights	6,592,034
Transaction
Reason for major shareholding notification New share issue
Date	03/11/2020
Limit for number of shares	10 %
Limit for number of votes	10 %
After the transaction
Quantity
Shares	6,592,034
Directly held voting rights	6,592,034
Indirectly held voting rights	0
Percentage
Directly held shares	5.62 %
Directly held voting rights	5.62 %
Indirectly held voting rights	0 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	5.62 %	6,592,034
Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled - Cash settled
Total	5.62 %	6,592,034
Group total holdings
Voting rights 6,592,034 Percentage of voting rights 5.62
Published 03/11/2020 13:56
Contact
Name Staffan Persson
Phone 0703210098	Email sp@swediacapital.se
CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25